Health
STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more
TL;DR
- The FDA approved a breast cancer drug from Roche, teeing up the launch of what the company has said could become its top-selling product
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 17, 2026 · Updated 11/17/2026, 2:39:00 PM · Reported with: STAT
Sources (1)
NRI Bytes writes its own articles from the reporting below.
STAT — STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and moreUp next · Health
GMA’s Gio Benitez shares ‘silent killer’ coronary artery disease diagnosis
Read next →
More stories

Health
Why frontline experience and operational research need to come together in the health sector
1h ago

Health
Auditor general can’t commit to timeline on Alberta health contract corruption probe
2h ago

Health
STAT+: Updated health data privacy rule sets standards for sharing records with apps
2h ago

Health
Transgender rights, healthcare should not be compromised
2h ago

